[en] BACKGROUND: Neurofilament light chain (NF-L) concentration is recognized to be modified in neurological diseases and traumatic brain injuries, but studies in the normal aging population are lacking. It is, therefore, urgent to identify influencing factors of NF-L concentration in the aging population. METHOD: We assessed NF-L concentration in sera of a large cohort of 409 community-dwelling adults aged over 65 years. We studied the association between NF-L and various physiological factors but also with self-reported comorbidities or life-style habits. RESULTS: We showed that NF-L concentration in serum was tightly associated with cystatin C concentration (r = 0.501, p < 0.0001) and consequently, to the estimated glomerular filtration rate (eGFR) (r = - 0.492; p < 0.0001). Additionally, NF-L concentration was dependent on age and body mass index (BMI) but not sex. Among the self-reported comorbidities, subjects who reported neurological disorders, cardiovascular diseases or history of fracture had higher NF-L concentration in univariate analysis, whereas it was only the case for subjects who reported neurological disorders in the multivariate analysis. NF-L concentration was also increased when Mini-Mental State Examination (MMSE) was decreased (≤ 25 points) but not when geriatric depression score (GDS) was increased (> 5 points) in both univariate and multivariate analysis. Finally, we are providing reference ranges by age categories for subjects with or without altered renal function. CONCLUSION: NF-L concentration in the aging population is not driven by the increasing number of comorbidities or depression. Yet, NF-L blood concentration is dependent on kidney function and NF-L interpretation in patients suffering from renal failure should be taken with caution.
Disciplines :
Public health, health care sciences & services Chemistry
Lengele, Laetitia ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Locquet, Médéa
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Cavalier, Etienne ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Language :
English
Title :
Neurofilament light chain concentration in an aging population.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Barro C, Chitnis T, Weiner HL (2020) Blood neurofilament light: a critical review of its application to neurologic disease. Ann Clin Transl Neurol 7:2508–2523 DOI: 10.1002/acn3.51234
O’Bryant SE (2019) Blood biomarkers for use in Alzheimer disease—moving from “if” to “how?” JAMA Neurol 76:1009–1010 DOI: 10.1001/jamaneurol.2019.0845
Li D, Mielke MM (2019) An update on blood-based markers of Alzheimer’s disease using the SiMoA platform. Neurol Ther 8:S73–S82 DOI: 10.1007/s40120-019-00164-5
Lambertsen KL, Soares CB, Gaist D et al (2020) Neurofilaments: the C-reactive protein of neurology. Brain Sci 10:56 DOI: 10.3390/brainsci10010056
Rosengren LE, Karlsson JE, Karlsson JO et al (1996) Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 67:2013–2018. 10.1046/j.1471-4159.1996.67052013.x DOI: 10.1046/j.1471-4159.1996.67052013.x
Kuhle J, Kropshofer H, Haering DA et al (2019) Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology 92:e1007–e1015. 10.1212/WNL.0000000000007032 DOI: 10.1212/WNL.0000000000007032
Hampel H, O’Bryant SE, Molinuevo JL et al (2018) Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol 14:639–652 DOI: 10.1038/s41582-018-0079-7
Constantinescu R, Rosengren L, Johnels B et al (2010) Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson’s disease and atypical Parkinsonian disorders. Park Relat Disord 16:142–145. 10.1016/j.parkreldis.2009.07.007 DOI: 10.1016/j.parkreldis.2009.07.007
Tiedt S, Duering M, Barro C et al (2018) Serum neurofilament light a biomarker of neuroaxonal injury after ischemic stroke. Neurology 91:e1338–e1347. 10.1212/WNL.0000000000006282 DOI: 10.1212/WNL.0000000000006282
Rosén H, Karlsson JE, Rosengren L (2004) CSF levels of neurofilament is a valuable predictor of long-term outcome after cardiac arrest. J Neurol Sci 221:19–24. 10.1016/j.jns.2004.03.003 DOI: 10.1016/j.jns.2004.03.003
Shahim P, Tegner Y, Marklund N et al (2018) Neurofilament light and tau as blood biomarkers for sports-related concussion. Neurology 90:e1780–e1788. 10.1212/WNL.0000000000005518 DOI: 10.1212/WNL.0000000000005518
Ferreira-Atuesta C, Reyes S, Giovanonni G et al (2021) The evolution of neurofilament light chain in multiple sclerosis. Front Neurosci 15:642384 DOI: 10.3389/fnins.2021.642384
Ashton NJ, Janelidze S, Al Khleifat A et al (2021) A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun 12:3400. 10.1038/s41467-021-23620-z DOI: 10.1038/s41467-021-23620-z
Khalil M, Pirpamer L, Hofer E et al (2020) Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun 11:812. 10.1038/s41467-020-14612-6 DOI: 10.1038/s41467-020-14612-6
Chen J, Yang X, Zhang Y et al (2020) Reference values for plasma neurofilament light chain (NfL) in healthy Chinese. Clin Chem Lab Med 59:e153–e156. 10.1515/cclm-2020-1030 DOI: 10.1515/cclm-2020-1030
Musso G, Plebani M (2019) Blood biomarkers in neurology: “a call to arms” for laboratory professionals. Clin Chem Lab Med 57:1433–1434. 10.1515/cclm-2019-0680 DOI: 10.1515/cclm-2019-0680
Beaudart C, Reginster JY, Petermans J et al (2015) Quality of life and physical components linked to sarcopenia: the SarcoPhAge study. Exp Gerontol 69:103–110. 10.1016/j.exger.2015.05.003 DOI: 10.1016/j.exger.2015.05.003
Inker LA, Schmid CH, Tighiouart H et al (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20–29. 10.1056/nejmoa1114248 DOI: 10.1056/nejmoa1114248
Altman DG (1990) Practical statistics for medical research. Chapman and Hall, London DOI: 10.1201/9780429258589
Levin A, Stevens PE, Bilous RW et al (2012) clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1
De Marchis GM, Katan M, Barro C et al (2018) Serum neurofilament light chain in patients with acute cerebrovascular events. Eur J Neurol 25:562–568. 10.1111/ene.13554 DOI: 10.1111/ene.13554
Akamine S, Marutani N, Kanayama D et al (2020) Renal function is associated with blood neurofilament light chain level in older adults. Sci Rep 10:20350. 10.1038/s41598-020-76990-7 DOI: 10.1038/s41598-020-76990-7
Korley FK, Goldstick J, Mastali M et al (2019) Serum NfL (neurofilament light chain) levels and incident stroke in adults with diabetes mellitus. Stroke 50:1669–1675. 10.1161/STROKEAHA.119.024941 DOI: 10.1161/STROKEAHA.119.024941
Hou YC, Huang CL, Lu CL et al (2021) The role of plasma neurofilament light protein for assessing cognitive impairment in patients with end-stage renal disease. Front Aging Neurosci 13:657794. 10.3389/fnagi.2021.657794 DOI: 10.3389/fnagi.2021.657794
Chung CC, Chan L, Chen JH et al (2020) Neurofilament light chain level in plasma extracellular vesicles and Parkinson’s disease. Ther Adv Neurol Disord. 10.1177/1756286420975917 DOI: 10.1177/1756286420975917
Zou LX, Sun L, Nicholas SB et al (2020) Comparison of bias and accuracy using cystatin C and creatinine in CKD-EPI equations for GFR estimation. Eur J Intern Med 80:29–34. 10.1016/j.ejim.2020.04.044 DOI: 10.1016/j.ejim.2020.04.044
Thelin EP, Zeiler FA, Ercole A et al (2017) Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review. Front Neurol 8:300 DOI: 10.3389/fneur.2017.00300
Uher T, McComb M, Galkin S et al (2021) Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis. Mult Scler J 27:220–231. 10.1177/1352458520912379 DOI: 10.1177/1352458520912379
Kalm M, Boström M, Sandelius Å et al (2017) Serum concentrations of the axonal injury marker neurofilament light protein are not influenced by blood-brain barrier permeability. Brain Res 1668:12–19. 10.1016/j.brainres.2017.05.011 DOI: 10.1016/j.brainres.2017.05.011
Andersson E, Janelidze S, Lampinen B et al (2020) Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer’s disease. Neurobiol Aging 95:143–153. 10.1016/j.neurobiolaging.2020.07.018 DOI: 10.1016/j.neurobiolaging.2020.07.018
Arseneau E, Balion CM (2016) Statistical methods used in the calculation of geriatric reference intervals: a systematic review. Clin Chem Lab Med 54:377–388 DOI: 10.1515/cclm-2015-0420
Horn PS, Pesce AJ (2003) Reference intervals: an update. Clin Chim Acta 334:5–23 DOI: 10.1016/S0009-8981(03)00133-5
Al Shweiki MR, Steinacker P, Oeckl P et al (2019) Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia. J Psychiatr Res 113:137–140. 10.1016/j.jpsychires.2019.03.019 DOI: 10.1016/j.jpsychires.2019.03.019
Katisko K, Cajanus A, Jääskeläinen O et al (2020) Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders. J Neurol 267:162–167. 10.1007/s00415-019-09567-8 DOI: 10.1007/s00415-019-09567-8
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
